Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Ann Thorac Surg. 2014 Aug 7;98(4):1207–1212. doi: 10.1016/j.athoracsur.2014.05.068

Table 1.

Patient Characteristics

Variable Control Group
(N=276)		 LIMA Group
(N=14)		 P
Patient age (years) 65.3 ± 10.5 68.1 ± 7.0 0.33
Gender (female) 134 (48.6) 4 (28.6) 0.14
History of tobacco use 168 (60.9) 13 (92.9) 0.50
Diabetes 44 (15.9) 4 (28.6) 0.23
Congestive heart failure 8 (2.9) 5 (35.7) <0.001
Coronary artery disease 43 (15.6) 14 (100.0) <0.001
Neoadjuvant chemotherapy 18 (6.5) 1 (7.1) 0.95
Neoadjuvant radiation therapy 11 (4.0) 0 0.44
DLCO (% predicted) 77.9 ± 20.4 73.5 ± 18.5 0.52
FEV1 (% predicted) 73.7 ± 20.9 71.3 ± 16.1 0.52

Values are presented as raw number [percent] or mean ± standard deviation. DLCO-diffusion capacity of the lung for carbon monoxide; FEV1-forced expiratory volume in 1 second; NSCLC-non-small cell lung cancer.